Merck invests $57M in vaccine manufacturing expansion at Wilson plant

Merck announced a $57 million expansion of its vaccine manufacturing capabilities at its Wilson, North Carolina campus, adding 55 new jobs. The expansion is for production of the RotaTeq rotavirus vaccine.

“Merck is delighted to announce its second significant investment at our Wilson plant in less than a year.”wraltechwire.com

• 2 sources
• wraltechwire.comMerck to invest $57M, add more jobs at Wilson vaccine plantWRAL TechWireDec 4, 2019
• wilsontimes.comMore jobs coming to MerckFrom staff reportsDec 5, 2019

Summarized from public sources; check the original articles before acting on it.